Isramco Negev 2 Limited Partnership (ISRA) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Isramco Negev 2 Limited Partnership ILS 1.79, price ILS 1.93, upside -7.0%, quality 72 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Isramco Negev 2 Limited Partnership for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range 0.4889 ILA – 2.50 ILA · fair‑value band 1.51 ILA – 2.35 ILA · the 1.93 ILA price screens above the 1.79 ILA fair value. Dashed = 300-day average. As of Oct 3, 2026.
Follow Isramco Negev 2 Limited Partnership in your weekly email
Every Wednesday you see whether Isramco Negev 2 Limited Partnership is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Isramco Negev 2 Limited Partnership engages in the exploration, development, and production of oil, natural gas, and condensate in Israel, Jordan, and Egypt. The company's properties include the Tamar and Dalit possession. It serves various customers, as well as Israel Electric Company Ltd.
Show more
Isramco Negev 2 Limited Partnership engages in the exploration, development, and production of oil, natural gas, and condensate in Israel, Jordan, and Egypt. The company's properties include the Tamar and Dalit possession. It serves various customers, as well as Israel Electric Company Ltd. Isramco Negev 2 LP was incorporated in 1989 and is based in Petah Tikva, Israel.
Stock analysis
Isramco Negev 2 Limited Partnership (ISRA) currently trades at 1.93 ILA, while our model-based Fair Value estimate is 1.79 ILA, so the stock looks roughly fairly valued today (gap 7.5%).
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 1.58 ILA per share, and 3 of the 24 models we run sit above the 1.93 ILA price.
Bear case: the Asset-Based group reads lowest at 0.4800 ILA, and 21 of the 24 models stay below the price. Evidence for this calculation is low.
Scenario range: 1.51 ILA (bear) to 2.35 ILA (bull), the price of 1.93 ILA sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 72/100 (solid quality), in the Energy sector.
Weak Growth: Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Isramco Negev 2 Limited Partnership reported revenue of $446M in FY2025 versus $410M in FY2021, a compound +2.1%/yr. Reported net income was $125M in FY2025.
Key figures
Market cap 5.0B ILA · P/E ratio 13.8 · P/S ratio 3.86 · EPS (TTM) 0.1400 ILA · Dividend yield 1.4% · Net margin 28.0% · Return on equity 19.8% · Return on assets (EBIT) 19.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (low confidence).
What moves the price
The share trades about 23% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Energy peers we cover trades at 10% fair-value upside, at −7%, ISRA screens richer than that median.
Fair Value models
Bear 1.51 ILAFair Value 1.79 ILABull 2.35 ILA
Price 1.93 ILA · Upside -7.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.0858 ILS per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Revenue growth 1 year
−16.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.5%
Start year 2020 (pandemic). Over 10 years: −0.6% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.5%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−14.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year−15.6%
Dividend (yield on the price)1.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−15.6% vs −7.4%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.60% → 41%
Start year 2020 (pandemic)
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+0.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −1.4% a year for the price.
Compare Isramco Negev 2 Limited Partnership with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Oil & Gas E&P · 272 stocks
Beats the industry median on 7/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score72 · Top 25%
Fair Value upside−6.9% · Below median
Profitability
Return on equity (TTM)19.8% · Top 25%
Return on assets8.6% · Top 25%
Net margin (TTM)28.2% · Top 25%
Operating margin (TTM)44.7% · Above median
Growth and dividend
Revenue growth10.9% · Below median
Dividend yield (TTM)1.4% · Below median
Balance sheet
Debt / equity0.65× · Highest 25%
Valuation Multiplesvs Oil & Gas E&P median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Isramco Negev 2 Limited Partnership (ISRA) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of 1.79 ILA versus a price of 1.93 ILA, about −7% upside (fairly valued).
What is the fair value of ISRA?
Our model-based fair value for Isramco Negev 2 Limited Partnership is 1.79 ILA (as of Oct 3, 2026), built from audited fundamentals. The current price: 1.93 ILA.
What is the quality score of ISRA?
Isramco Negev 2 Limited Partnership has a Quality Score of 72/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Isramco Negev 2 Limited Partnership (ISRA)?
Our model-based price target is the fair value of 1.79 ILA (as of Oct 3, 2026) from 24 valuation models. Cautious scenario 1.51 ILA, optimistic scenario 2.35 ILA. It is a calculation from audited fundamentals, not an analyst target.
What is the Isramco Negev 2 Limited Partnership stock forecast for 2026?
Our models put fair value at 1.79 ILA, about −7% upside versus a price of 1.93 ILA (fairly valued). Cautious scenario 1.51 ILA, optimistic scenario 2.35 ILA. The calculation is refreshed regularly with new filings.
What is the revenue of Isramco Negev 2 Limited Partnership (ISRA)?
Isramco Negev 2 Limited Partnership reported trailing-twelve-month revenue of about $423M (latest available figure, as of Oct 3, 2026).
Does Isramco Negev 2 Limited Partnership pay a dividend?
Isramco Negev 2 Limited Partnership currently shows a dividend yield of about 1.40% relative to its recent price (as of Oct 3, 2026).
What growth is priced into Isramco Negev 2 Limited Partnership (ISRA)?
For today's price to be fair in a discounted-cash-flow model, Isramco Negev 2 Limited Partnership would have to grow free cash flow by +0.9 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +0.5 % per year. As of Oct 3, 2026.
What discount rate (WACC) does the fair value of ISRA use?
Our models discount Isramco Negev 2 Limited Partnership at 11.6 %: a base by market capitalisation (small), damped by beta 0.06, country premium for Israel. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Isramco Negev 2 Limited Partnership that is +0.9 % per year a year over ten years, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has Isramco Negev 2 Limited Partnership (ISRA) delivered so far?
Over the past 5 years revenue at Isramco Negev 2 Limited Partnership grew +0.5 % a year. The price currently implies +0.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Isramco Negev 2 Limited Partnership (ISRA) growing?
The median revenue growth in the sector is +11.4 % a year. That is the yardstick for the growth priced into Isramco Negev 2 Limited Partnership (+0.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Isramco Negev 2 Limited Partnership (ISRA)?
The free-cash-flow yield on the price is 11.86 %: that much free cash flow Isramco Negev 2 Limited Partnership produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Isramco Negev 2 Limited Partnership (ISRA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Isramco Negev 2 Limited Partnership it is 1.79 ILA per share (as of Oct 3, 2026), against a price of 1.93 ILA. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Isramco Negev 2 Limited Partnership stock overvalued or undervalued in 2026?
As of Oct 3, 2026, ISRA trades above its calculated fair value: price 1.93 ILA, fair value 1.79 ILA, a gap of about −7% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ISRA?
No. The price is what the market pays today (1.93 ILA); the fair value is what the company's own numbers justify (1.79 ILA). For Isramco Negev 2 Limited Partnership the two are 0.1340 ILA per share apart. That gap is exactly why we show both numbers side by side.
How much is Isramco Negev 2 Limited Partnership worth?
The market values Isramco Negev 2 Limited Partnership at about 5.0B ILA (market capitalisation, as of Oct 3, 2026). Per share that is 1.93 ILA; our models calculate a fair value of 1.79 ILA per share.
What do the bullish and bearish scenarios say about ISRA?
Our models span a range for Isramco Negev 2 Limited Partnership: cautious scenario 1.51 ILA, base 1.79 ILA, optimistic 2.35 ILA per share (as of Oct 3, 2026, price 1.93 ILA). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ISRA?
Isramco Negev 2 Limited Partnership trades at a price-to-earnings ratio of 13.8 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1.79 ILA is built from several models across several years. Other multiples: P/B 2.7, P/S 3.9, EV/EBITDA 8.3.
How solid is the balance sheet of Isramco Negev 2 Limited Partnership (ISRA)?
Balance-sheet figures for Isramco Negev 2 Limited Partnership (as of Oct 3, 2026): return on equity 19.8%, debt of 0.65 per unit of equity. They feed the Quality Score of 72/100, which measures business quality independently of the share price.
How far is ISRA from its 52-week high?
Isramco Negev 2 Limited Partnership trades at 1.93 ILA, about 23% below its 52-week high of 2.50 ILA and 7% above the low of 1.81 ILA (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of 1.79 ILA is for.
Which stocks are comparable to Isramco Negev 2 Limited Partnership?
From the same area (Energy) we also value ConocoPhillips explores for,, CNOOC Limited, Canadian Natural Resources Limited, EOG Resources, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Isramco Negev 2 Limited Partnership stock attractive at the current price?
The data as of Oct 3, 2026: price 1.93 ILA, calculated fair value 1.79 ILA (−7%), Quality Score 72/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ISRA calculated?
We run Isramco Negev 2 Limited Partnership through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1.79 ILA, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Isramco Negev 2 Limited Partnership itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Isramco Negev 2 Limited Partnership (ISRA)?
The closing price on Oct 1, 2026 was 1.93 ILA. Our model-based fair value is 1.79 ILA, about −7% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Isramco Negev 2 Limited Partnership right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Isramco Negev 2 Limited Partnership
How large is the market capitalisation of Isramco Negev 2 Limited Partnership (ISRA)?
The market capitalisation of Isramco Negev 2 Limited Partnership is 5.0B ILA. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Isramco Negev 2 Limited Partnership (ISRA)?
The price-to-sales ratio of Isramco Negev 2 Limited Partnership is 3.86 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Isramco Negev 2 Limited Partnership (ISRA)?
Earnings per share at Isramco Negev 2 Limited Partnership are 0.1400 ILA (price ÷ EPS = P/E 13.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Isramco Negev 2 Limited Partnership (ISRA)?
The dividend yield of Isramco Negev 2 Limited Partnership is 1.4% (payout 19.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Isramco Negev 2 Limited Partnership (ISRA)?
The net margin of Isramco Negev 2 Limited Partnership is 28.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Isramco Negev 2 Limited Partnership (ISRA)?
The return on equity (ROE) of Isramco Negev 2 Limited Partnership is 19.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Isramco Negev 2 Limited Partnership (ISRA)?
On an EBIT basis the return on assets of Isramco Negev 2 Limited Partnership is 19.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Isramco Negev 2 Limited Partnership (ISRA)?
The operating margin of Isramco Negev 2 Limited Partnership is 44.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Isramco Negev 2 Limited Partnership (ISRA)?
Revenue at Isramco Negev 2 Limited Partnership is growing +10.9% versus a year earlier (3y avg −4.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Isramco Negev 2 Limited Partnership (ISRA)?
Earnings per share at Isramco Negev 2 Limited Partnership are growing +19.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Isramco Negev 2 Limited Partnership (ISRA) carry?
The net debt of Isramco Negev 2 Limited Partnership is $402M (fiscal year 2025, ≈ 2.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Isramco Negev 2 Limited Partnership in the live analysis
One click puts Isramco Negev 2 Limited Partnership on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
